Category: Featured Content
-
Trading Places: Gamestop (GME.NYSE) has Wall Street shitting bricks because ‘the poors’ figured out their scam
A friend said his Twitter timeline today looks like the last 15 minutes of the movie Trading Places, and he’s right. In what may have been the world’s most effective troll event, Reddit users at r/wallstreetbets got together and decided the insane level of short selling on some companies by billionaire finance bros might be…
-
Gold Mountain Mining (GMTN.V) signs ore purchase agreement, continues move towards production
For weeks, we’ve been talking about how Gold Mountain Mining (GMTN.V) CEO Kevin Smith (not my old movie writer/director boss Kevin Smith, but the ‘dig ore out of the ground’ Kevin Smith) has his head set on getting GMTN to low level production sooner rather than later. It’s a different business model from many in…
-
Heritage Cannabis Holdings (CANN.C) closes the door on Premium 5 acquisition and refines growth strategy
Heritage Cannabis Holdings (CANN.C) closed its acquisition of Canadian-based recreational and medical cannabis company, Premium 5, today, according to a press release. Premium 5 products have stretched to retailers across eight provinces, and is one of the only concentrate brands available to medical patterns from coast to coast through both the Shoppers Drug Mart and…
-
PredictMedix (PMED.C), CFO SECRETLY SOLD SHARES??? (*CLICKBAIT*)
Ok weekenders, let’s talk PMED. For the newbies in the room, PMED is PredictMedix Inc, a biotech company Equity Guru’s been working with for the past little bit. (Of course, this doesn’t change the fact that we’re still big on holding people accountable – client or not. See recent example here.) PMED as a business…
-
Medexus Pharmaceuticals (MDP.V), poised for flight on the Nasdaq (coming soon)
If you are like me and health sciences is your sector of choice when it comes to investing in the markets, you’d better be very patient, love doing research – and a willingness to see it through!!! A sector famous for its high-risk-high-reward characteristics is definitely not recommended for the faint of heart. Lucky for…
-
Canntab Therapeutics (PILL.C): The Canadian weed sector is struggling, but new consumer products have room to scale
If we’re honest about it – if we’re REALLY honest about it – Canada has fumbled its advantage in the cannabis sector. First to market, first to raise hundreds of millions in financing, first to legalize, first to recreationalize (not a word but I’m on a roll), and it’s all really been for naught. In…